Recombitek Oral Bordetella Recombitek Oral Bordetella Recombitek Oral Bordetella oral vaccine has shown to be effective against canine infectious tracheobronchitis caused by Bordetella bronchiseptica, the company reported. Clinical studies suggest that as a mucosal vaccine, it offers dogs a robust immune response after a single dose administered into the dog’s buccal cavity, according to the manufacturer. Backed by the Pet Vaccines Customer Satisfaction Guarantee. Recombitek Oral Bordetella oral vaccine has shown to be effective against canine infectious tracheobronchitis caused by Bordetella bronchiseptica, the company reported. Clinical studies suggest that as a mucosal vaccine, it offers dogs a robust immune response after a single dose administered into the dog’s buccal cavity, according to the manufacturer. Backed by the Pet Vaccines Customer Satisfaction Guarantee. Not Available All information listed in this section was submitted by the respective companies. Kenilworth Media Inc. cannot assume responsibility for errors of relevance, fact or omission.
